Apixaban (Eliquis) – Blood Clot Prevention

Apixaban (Eliquis) – Blood thinner, widely known as Eliquis, is a trusted oral anticoagulant that prevents harmful blood clots and strokes. It blocks Factor Xa, a key protein in clot formation, helping blood flow smoothly through the body. Healthcare providers often prescribe Eliquis for atrial fibrillation, deep vein thrombosis, or pulmonary embolism. With reliable protection, Eliquis supports cardiovascular health and reduces the risk of serious clot-related complications.

What is Apixaban?

Apixaban, sold under the brand name Eliquis, is a direct oral anticoagulant (DOAC) that prevents dangerous blood clots. It works by blocking Factor Xa, a key protein involved in clot formation. Eliquis is prescribed to reduce stroke risk in atrial fibrillation patients without heart valve disease. Additionally, it treats and prevents deep vein thrombosis (DVT) and pulmonary embolism (PE), offering reliable protection for long-term cardiovascular and circulatory health.

Benefits of Apixaban (Eliquis)

• Prevents strokes: Reduces stroke risk in atrial fibrillation patients.
• Treats DVT and PE: Effective in managing blood clots.
• Lower bleeding risk: Compared to older anticoagulants.
• No routine monitoring: Unlike warfarin, it does not require frequent blood tests.

Patients take Apixaban (Eliquis) – Blood thinner twice daily and should avoid stopping it without medical supervision.

–  In addition, it treats and prevents deep vein thrombosis (DVT) and pulmonary embolism (PE), offering reliable protection for long-term cardiovascular and circulatory health.